LEVETIRACETAM DEXCEL 250

Страна: Израел

Език: английски

Източник: Ministry of Health

Активна съставка:

LEVETIRACETAM

Предлага се от:

DEXCEL PHARMA TECHNOLOGIES LTD

АТС код:

N03AX14

Лекарствена форма:

TABLETS

Композиция:

LEVETIRACETAM 250 MG

Начин на приложение:

PER OS

Вид предписание :

Required

Произведено от:

DEXCEL LTD, ISRAEL

Терапевтична група:

LEVETIRACETAM

Терапевтична област:

LEVETIRACETAM

Терапевтични показания:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Дата Оторизация:

2018-03-31